Get the Stockscreener App
2.97
2.62%
-0.08
Pre-market:
3.35
0.38
+12.79%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $2.97, with a volume of 80,334.
It is down -2.62% in the last 24 hours and down -16.34% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$3.05
Open:
$3
24h Volume:
80,334
Relative Volume:
0.59
Market Cap:
$3.18M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-6.4565
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-3.26%
1M Performance:
-16.34%
6M Performance:
-55.57%
1Y Performance:
-93.65%
1-Day Range:
$2.91
$3.0552
1-Week Range:
$2.91
$3.25
52-Week Range:
$2.91
$48.75
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
2.97 | 3.27M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals (NASDAQ: SHPH) Harnesses AI to Transform Cancer Drug Discovery - openPR.com
Shuttle Pharmaceuticals Announces Above-the-Market $2.5 Million Private Placement at Effective Price per Share of $4.00 - Newsfile
Shuttle Pharma (NASDAQ: SHPH) to issue 625,156-share pre-funded warrant; $2.5M placement - Stock Titan
What technical charts say about Shuttle Pharmaceuticals Holdings Inc. stockJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
Best data tools to analyze Shuttle Pharmaceuticals Holdings Inc. stock2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Can Shuttle Pharmaceuticals Holdings Inc. stock deliver surprise earnings beat2025 Dividend Review & Risk Managed Investment Strategies - newser.com
Will Shuttle Pharmaceuticals Holdings Inc. stock deliver shareholder valueEarnings Risk Summary & Smart Investment Allocation Insights - newser.com
What risks investors should watch in Shuttle Pharmaceuticals Holdings Inc. stock2025 EndofYear Setup & Verified Momentum Stock Alerts - newser.com
Does Shuttle Pharmaceuticals Holdings Inc. show high probability of reboundBull Run & Technical Confirmation Trade Alerts - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. meeting your algorithmic filter criteriaJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - newser.com
Risk adjusted return profile for Shuttle Pharmaceuticals Holdings Inc. analyzedCEO Change & Short-Term High Return Ideas - newser.com
Shuttle Pharmaceuticals Holdings Inc. stock trend outlook and recovery pathTake Profit & Reliable Price Action Trade Plans - newser.com
Analyzing recovery setups for Shuttle Pharmaceuticals Holdings Inc. investorsTrade Volume Summary & Technical Pattern Based Signals - newser.com
Is Shuttle Pharmaceuticals Holdings Inc. a candidate for recovery playJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
How to integrate Shuttle Pharmaceuticals Holdings Inc. into portfolio analysis tools2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - newser.com
How Shuttle Pharmaceuticals Holdings Inc. stock reacts to inflationary pressuresJuly 2025 Catalysts & Free Safe Entry Trade Signal Reports - newser.com
Full technical analysis of Shuttle Pharmaceuticals Holdings Inc. stockBear Alert & Risk Controlled Daily Plans - newser.com
How Shuttle Pharmaceuticals Holdings Inc. stock performs after earningsQuarterly Earnings Summary & Daily Oversold Bounce Ideas - newser.com
Shuttle Pharmaceuticals’ Promising Phase 2 Study on Glioblastoma Treatment - TipRanks
How to manage a losing position in Shuttle Pharmaceuticals Holdings Inc.Quarterly Portfolio Summary & Community Verified Watchlist Alerts - newser.com
Can Shuttle Pharmaceuticals Holdings Inc. stock hit analyst price targets2025 Earnings Surprises & Stock Timing and Entry Methods - fcp.pa.gov.br
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):